PCVX
Vaxcyte Inc

743
Mkt Cap
$6.03B
Volume
276,565.00
52W High
$94.60
52W Low
$27.66
PE Ratio
-9.36
PCVX Fundamentals
Price
$45.54
Prev Close
$46.07
Open
$46.54
50D MA
$43.59
Beta
0.73
Avg. Volume
1.43M
EPS (Annual)
-$3.80
P/B
2.07
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Vaxcyte (NASDAQ:PCVX) Shares Gap Down - Here's What Happened
Vaxcyte (NASDAQ:PCVX) Shares Gap Down - Time to Sell...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Vaccine Stocks Fall After FDA Plans to Impose Stricter Vaccine Rules
Shares of vaccine makers slide as an internal FDA memo on vaccine safety and plans for stricter rules spark broad pressure across the overall industry.
Zacks·3d ago
News Placeholder
Vaccine Stocks Drop After FDA Memo Links COVID Shots To Child Deaths
Vaccine Stocks Drop After FDA Memo Links COVID Shots To Child Deaths Vaccine stocks slumped Monday after an explosive memo from FDA vaccine chief Vinay Prasad surfaced late Friday, signaling the...
Zero Hedge·4d ago
News Placeholder
XTX Topco Ltd Has $1.36 Million Position in Vaxcyte, Inc. $PCVX
XTX Topco Ltd grew its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 202.1% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned...
MarketBeat·5d ago
News Placeholder
Universal Beteiligungs und Servicegesellschaft mbH Lowers Position in Vaxcyte, Inc. $PCVX
Universal Beteiligungs und Servicegesellschaft mbH trimmed its holdings in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 76.0% in the 2nd quarter, according to the company in its most recent...
MarketBeat·7d ago
News Placeholder
Franklin Resources Inc. Lowers Stock Position in Vaxcyte, Inc. $PCVX
Franklin Resources Inc. reduced its position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 69.6% during the second quarter, according to its most recent disclosure with the Securities and...
MarketBeat·7d ago
News Placeholder
DNB Asset Management AS Acquires 6,924 Shares of Vaxcyte, Inc. $PCVX
DNB Asset Management AS raised its holdings in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 70.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange...
MarketBeat·8d ago
News Placeholder
Vaxcyte, Inc. (NASDAQ:PCVX) Receives Consensus Rating of "Moderate Buy" from Brokerages
Shares of Vaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the ten analysts that are presently covering the stock, Marketbeat Ratings...
MarketBeat·8d ago
News Placeholder
Neo Ivy Capital Management Takes $788,000 Position in Vaxcyte, Inc. $PCVX
Neo Ivy Capital Management purchased a new position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange...
MarketBeat·12d ago
News Placeholder
Leerink Partnrs Decreases Earnings Estimates for Vaxcyte
Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) - Stock analysts at Leerink Partnrs dropped their FY2025 earnings per share (EPS) estimates for Vaxcyte in a note issued to investors on Tuesday, November...
MarketBeat·13d ago

Latest PCVX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.